Most important in brief
- The building blocks are surgery and radiotherapy, chemotherapy, immunotherapy, targeted tablets and antibodies. They are often combined.
- At an early stage there are often three steps: before surgery, the main treatment and afterwards.
- In stage IV, treatment goes line by line. The test result helps decide whether a tablet or immunotherapy comes first.
- Which chemotherapy fits also depends on the form, adenocarcinoma or squamous cell carcinoma.
This page explains non-small cell lung cancer (NSCLC). Small cell lung cancer is tested and treated differently. Everything about it on its own page →
The main types of treatment
Which treatment is suitable depends on the stage, your general health and the features of the tumour. Often several treatments are combined.
| Treatment | What happens | When it may be used |
|---|---|---|
| Surgery | The tumour is removed, usually with one lobe of the lung. | Mainly in stages I to IIIA, when it can be removed completely. |
| Radiotherapy | Targeted radiation: very precise in a few sessions (SBRT), together with chemo, or to ease symptoms. | At any stage, with different aims. |
| Chemotherapy | Medicines attack dividing cells. Usually two together, one of them containing platinum. | At any stage, often together with immunotherapy or radiotherapy. |
| Immunotherapy | Releases a brake on the immune system so it recognises the cancer. | Without a matching tablet often as the first treatment; also before or after surgery. The PD-L1 level helps choose. |
| Targeted tablet | Blocks a specific change in the tumour. | When a matching change has been found; depending on the change as the first or a later treatment, with EGFR and ALK also after surgery. |
| Antibody | Proteins that attach to cancer cells or blood vessels. Some bring in immune cells (bispecific), some carry a chemo drug directly to the cell (antibody-drug conjugate). | Depending on the test result and line, usually together with other medicines. |
| Supportive care | Eases pain, breathlessness, nausea and other symptoms. | Always, from the start. |
The colours are the same as in My path. There, every building block opens a profile.
Early stage: before, main treatment, afterwards
In stages I to III the aim is usually cure. Treatment then often has three steps. The tumour board decides which of them fit you.
| Step | Option | When |
|---|---|---|
| Before surgery | Chemotherapy with immunotherapye.g.++or++or++ | Often for stage II–III when surgery is possible. The chemo depends on the tissue type: for adenocarcinoma usually with pemetrexed, for squamous cell carcinoma with paclitaxel or gemcitabine. Nivolumab only with PD-L1 of 1% or more. |
| Main treatment | When the tumour can be removed completely. | |
For a small tumour, when surgery is not possible. | ||
e.g.++or++or++ | For stage III, when surgery is not possible. Chemo and radiotherapy at the same time; pemetrexed only for adenocarcinoma. | |
| Afterwards | Immunotherapy after chemoradiotherapye.g. | For stage III, PD-L1 of 1% or more, for up to 12 months. |
Immunotherapy after surgerye.g. | After platinum chemotherapy, with a high risk of return, at any PD-L1 level. | |
Immunotherapy after surgery, with high PD-L1e.g. | After platinum chemotherapy, only with PD-L1 of 50% or more. | |
Continue immunotherapye.g.oror | If it was already given with chemotherapy before surgery. | |
Chemotherapye.g.+or+ | After surgery for some stages, to lower the risk of return. Pemetrexed only for adenocarcinoma; carboplatin instead of cisplatin is possible. | |
| If it comes back | Treatment as in stage IV | If the cancer comes back elsewhere, it is usually treated line by line with medicines, as in stage IV. A new test is often done then. |
Local treatment again | If it comes back in just one place, surgery or radiotherapy is sometimes possible again, aimed at cure. | |
| Alongside | Supportive care | For symptoms, from the start. |
Rehabilitation, breathing exercises and stopping smoking | Help recovery and lower the risk of complications. |
With EGFR or ALK, a tablet after surgery is an option instead of immunotherapy (EGFR, ALK and ROS1). Simplified, examples without ranking.
First and later treatment
In stage IV, doctors talk about “lines” of treatment. First-line is the first treatment that works throughout the body. If the cancer grows again later, or the treatment is not tolerated, a second-line treatment follows.
Which treatment fits in which line also depends on the test results. This is how the professional guidelines from ESMO and Onkopedia describe it.
Clear explanations written for patients are in the ESMO patient guide on NSCLC and the NCCN guidelines for patients (the NCCN site may ask you to register).
Chemotherapy: which, when, with what
Chemotherapy for lung cancer usually combines two medicines, one of them containing platinum: carboplatin or cisplatin. The partner depends on the form. Pemetrexed only fits adenocarcinoma; paclitaxel or gemcitabine fit squamous cell carcinoma. Immunotherapy is often added.
| Situation | Chemotherapy | Good to know |
|---|---|---|
| First treatment in stage IV | Immunotherapy with chemo, for adenocarcinomae.g.++or++or+++or+++ | At any PD-L1 level. Cisplatin instead of carboplatin is possible. With nivolumab + ipilimumab only two chemo cycles. |
Immunotherapy with chemo, for squamous cell carcinomae.g.++or++or+++ | At any PD-L1 level. With nivolumab + ipilimumab only two chemo cycles. | |
| When immunotherapy is not suitable | Chemo alone, for adenocarcinomae.g.+ | When immunotherapy is not suitable. Cisplatin instead of carboplatin is possible. |
Chemo alone, for squamous cell carcinomae.g.+or+ | When immunotherapy is not suitable. | |
| Early stage | Chemotherapy with immunotherapye.g.++or++or++ | Often for stage II–III when surgery is possible. The chemo depends on the tissue type: for adenocarcinoma usually with pemetrexed, for squamous cell carcinoma with paclitaxel or gemcitabine. Nivolumab only with PD-L1 of 1% or more. |
Chemotherapye.g.+or+ | After surgery for some stages, to lower the risk of return. Pemetrexed only for adenocarcinoma; carboplatin instead of cisplatin is possible. | |
Chemoradiotherapye.g.++or++or++ | For stage III, when surgery is not possible. Chemo and radiotherapy at the same time; pemetrexed only for adenocarcinoma. | |
| After a tablet | Platinum chemoe.g.+ | When the tablet stops working. |
| Later line | Chemo alonee.g. | When the first treatment stops working. |
Chemo with an antibodye.g.+ | When the first treatment stops working. | |
Chemo with a tablet, for adenocarcinomae.g.+ | Nintedanib only for adenocarcinoma. |
Simplified, examples without ranking.
How chemotherapy works in practice
- Where
- In the day clinic, as an infusion
- How long
- Usually 4 to 6 cycles, about 3 to 4 months
- Check-ups
- Blood count, kidney and liver values before each cycle
- What to watch for
- Take a fever over 38 °C seriously and report it at once. Avoid crowds and sick people when blood counts are low. Discuss vaccinations beforehand.
What helps with nausea, tiredness or hair loss is under Living with it.
Targeted medicines depending on your test result
Whether a targeted medicine is suitable depends on the biomarker test results. For some changes, for example EGFR, ALK or ROS1, it is often the very first treatment.
For others, for example KRAS G12C, it is usually a later treatment in the EU (ESMO; Onkopedia).
| Change | First treatment | Later |
|---|---|---|
| EGFR | Targeted tablet, alone or combined.e.g.or+ | Antibody with chemotherapy, chemotherapy, or a trial.e.g.++ |
| ALK | ALK tablet.e.g.oror | Another ALK tablet depending on a new test, or chemotherapy.e.g. |
| ROS1 | ROS1 tablet.e.g.oror | Another ROS1 tablet, or chemotherapy.e.g. |
| KRAS G12C | Usually immunotherapy, often with chemotherapy. | KRAS G12C tablet, after a first treatment.e.g.or |
| BRAF V600E | Two tablets together (BRAF and MEK inhibitors).e.g.+or+ | Immunotherapy or chemotherapy, if not given yet. |
| MET exon 14 | Usually immunotherapy, often with chemotherapy. | MET tablet, after immunotherapy or platinum chemotherapy.e.g.or |
| RET | RET tablet.e.g. | Immunotherapy or chemotherapy, if not given yet. |
| NTRK | Usually the standard treatment first. | NTRK tablet, when other treatments are not suitable.e.g.or |
| HER2 | Usually immunotherapy, often with chemotherapy. | Antibody-drug conjugate by infusion, after platinum chemotherapy.e.g. |
| Other KRAS forms | Usually immunotherapy, often with chemotherapy. | Chemotherapy. New medicines against these forms are being tested in trials. |
Simplified, as of November 2026, examples without ranking. More on each change via the links in the table, and on testing under Tests.
Questions to ask about treatment
Why ask?
Cure, long-term control or relief: the aim decides how much burden makes sense.
Why ask?
There is often more than one way; the reasoning helps you take part in the decision.
Why ask?
Some changes matter straight away, others only for the next treatment.
Why ask?
Every treatment has its own side effects; knowing them lets you act early.
Why ask?
Availability and coverage differ from country to country.
